Human mouse chimeric CD7 monoclonal antibody (SDZCHH380) for the prophylaxis of kidney transplant rejection: analysis beyond 4 years.
Sharma, L C
Human mouse chimeric CD7 monoclonal antibody (SDZCHH380) for the prophylaxis of kidney transplant rejection: analysis beyond 4 years. [electronic resource] - Transplantation proceedings - 323-4 p. digital
Publication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
0041-1345
10.1016/s0041-1345(97)82528-6 doi
Animals
Antibodies, Monoclonal--therapeutic use
Creatinine--blood
Follow-Up Studies
Graft Rejection--prevention & control
Humans
Immunosuppression Therapy
Kidney Transplantation--immunology
Mice
Muromonab-CD3--therapeutic use
Recombinant Fusion Proteins--therapeutic use
Time Factors
Human mouse chimeric CD7 monoclonal antibody (SDZCHH380) for the prophylaxis of kidney transplant rejection: analysis beyond 4 years. [electronic resource] - Transplantation proceedings - 323-4 p. digital
Publication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
0041-1345
10.1016/s0041-1345(97)82528-6 doi
Animals
Antibodies, Monoclonal--therapeutic use
Creatinine--blood
Follow-Up Studies
Graft Rejection--prevention & control
Humans
Immunosuppression Therapy
Kidney Transplantation--immunology
Mice
Muromonab-CD3--therapeutic use
Recombinant Fusion Proteins--therapeutic use
Time Factors